BioElectronics’ ActiPatch Exhibits At Australia’s Major Pharmaceutical Event

FREDERICK, MD–(Marketwired – Mar 13, 2017) –  BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced noninvasive bioelectronic pain management medical devices, is pleased to announce that its devices are being featured at the Australian Pharmacy Professional Conference and Trade Exhibition. The conference and trade exhibition is the largest pharmaceutical event in Australia with 232 exhibitors … Continue Reading

BioElectronics Announces ActiPatch® Available on Amazon

FREDERICK, MD, USA, BioElectronics Corporation (OTC Pink: BIEL), February 9, 2017 8:30 AM, the maker of advanced pain management medical devices, today announced that ActiPatch® Musculoskeletal Pain Therapy device is now available on the US Amazon.com. ActiPatch is the leading nonprescription pain therapy in the United Kingdom with over 300 reviews that rate the device … Continue Reading

BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch® Musculoskeletal Pain Therapy

FREDERICK, MD, USA, February 5, 2017 — BioElectronics Corporation (OTC Pink: BIEL), the maker of wearable pain therapy devices, announced today that it has received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to (1) plantar fasciitis of the heel; and (2) osteoarthritis of the … Continue Reading

BioElectronics Comments on its U.S. FDA’s OTC Market Clearance Application

FREDERICK, Md., Oct. 10, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced disposable electroceutical devices, announced that on Monday, October 3rd, 2016 it met with senior management from the FDA’s Division of Neurological and Physical Medicine Devices, including the Deputy Division Director, the Acting Branch Chief of the Physical Medicine and … Continue Reading

BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication

FREDERICK, Md., Sept. 28, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced neuromodulation medical devices announced that it has submitted a paper: “ActiPatch© Central Sensitization Therapy: A Chronic Back Pain Registry Study of Pain Relief & Analgesic Adverse Effects” for publication. The study reports that the majority of chronic back pain sufferers have … Continue Reading

BioElectronics Launches ActiPatch®, Musculoskeletal Pain Therapy In Sweden

FREDERICK, Md., Sept.13, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Sweden distributor, Harmony Health, Sweden, AB , has received initial stocking orders for Pharmacy Heart,www.apotekhjartat.se and the Life health products chain, www.lifebutiken.se.  Life health products are a chain of 220 stores and Pharmacy … Continue Reading

BioElectronics Corporation Engages Adam Staelin As Executive Vice President of Sales and Marketing

FREDERICK, Md., May 11, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has engaged Adam Staelin as the Executive Vice President of Sales and Marketing. Mr. Staelin has 20 years of sales and marketing experience and has held major management roles at Teradata and Valassis.  While at Teradata, a … Continue Reading

BioElectronics Responds to U.S. FDA’s Comments on its Market Clearance Application

FREDERICK, Md., May 10, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices, announced that it remains in negotiations with the U.S. Food and Drug Administration (“FDA”) regarding its  510(k) premarket notification for the ActiPatch® Musculoskeletal Pain Therapy. Two weeks ago, it submitted detailed responses to the FDA’s questions related to the … Continue Reading

BioElectronics’ Drug-free ActiPatch® Pain Therapy Highlighted in UK’s Express Newspaper on Dangers of Excessive Drug Use

FREDERICK, Md., April 28, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its drug-free ActiPatch® product  was noted in the United Kingdom’s Express Newspaper Health Section,  http://www.express.co.uk/life-style/health/664330/arthritis-pain-pills-warning-sufferers-taking-too-many-drugs-fight-agony.  The paper has a circulation of 400,000 that will increase the awareness of ActiPatch therapy for arthritis and chronic pain. The … Continue Reading

BioElectronics’ ActiPatch® Chronic Pain Therapy Featured In UK’s Leading Daily Mail Newspaper Health Section

BioElectronics’ ActiPatch® Chronic Pain Therapy Featured In UK’s Leading Daily Mail Newspaper Health Section FREDERICK, MD, USA, March 29, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its ActiPatch® product’s were featured in the United Kingdom’s leading Daily Mail’s Sunday Health Section, http://www.dailymail.co.uk/health/article-3555221/The-20-pulsing-skin-patch-end-misery-chronic-pain-arthritis-sufferers-diabetics.html. … Continue Reading